Revolution Medicines starts shipping experimental pancreatic cancer drug - statnews.com
Source:STAT
CEO Mark Goldsmith says Revolution Medicines will submit pancreatic cancer drug daraxonrasib for FDA approval soon.
Related Articles
Anthropic launches new push for enterprise agents with plugins for finance, engineering, and design - TechCrunch
It’s a major opportunity to grow Anthropic’s enterprise client base — and a significant threat …
Oil Market Runs Down Safety Cushion as Supply Shock Worsens - Crude Oil Prices Today | OilPrice.com
Global oil inventories are plunging at record speed as strategic reserves and commercial stockpiles …
Michael Burry warns Bitcoin selloff could trigger a “death spiral” - report (GBTC:NYSEARCA) - Seeking Alpha
Michael Burry warns Bitcoin could face a “death spiral,” pressuring corporate holders, miners, and …
Woman charged over abandoning dog at Las Vegas airport - BBC
A charity says it has been inudated with applications to adopt the dog after it was tied to the …